3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
3
Oligodendroglioma
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Melanoma
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Anus Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Splenomegaly
1
Skin Neoplasms
1
Interventions
Doxorubicin
14
Radiotherapy
10
Ifosfamide
10
Trabectedin
7
pazopanib
4
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
temsirolimus
2
romidepsin
2
ribociclib
2
pegfilgrastim
2
eribulin
2
cixutumumab
2
brigimadlin
2
belinostat
2
Vincristine
2
Sunitinib
2
Radiotherapy, Conformal
2
Gemcitabine
2
Epirubicin
2
Dexamethasone
2
Dactinomycin
2
Carboplatin
2
soblidotin
1
sitravatinib
1
siremadlin
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Liposarcoma
×
Quality of Life
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled